Portage Biotech Inc. (PRTG) Misses Q2 EPS by 98c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts PRTG Hot Sheet
Join SI Premium – FREE
Portage Biotech Inc. (NASDAQ: PRTG) reported Q2 EPS of ($1.25), $0.98 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Portage Biotech Inc. (PRTG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Millrose Properties, Inc. (MRP) Tops Q3 EPS by 2c
- First Financial (THFF) Tops Q3 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
